A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome

QR Code

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome

Maria Vadalà,1,2 Valentina Sunseri Trapani,1 Giulia Guarrasi,1 Nicasio Ventura,1 Massimo Castellucci,1 Salvatore Cillino1 1Biomedicine, Neuroscience and Advanced Diagnostic Department, University of Palermo, Palermo, Italy; 2IEMEST, Euro-Mediterranean Institute of Science and Technology,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Vadalà M, Sunseri Trapani V, Guarrasi G, Ventura N, Castellucci M, Cillino S
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	dexamethasone implant diabetic macular edema intravitreal implants ozurdex real-world inflammation Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/0df633b46a2245c2b8035d9759a7fbe4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
par: Urbančič M, et autres
Publié: (2019)

Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
par: Chhablani J, et autres
Publié: (2018)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
par: Udaondo P, et autres
Publié: (2021)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
par: Coelho J, et autres
Publié: (2019)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
par: Zola M, et autres
Publié: (2017)

Outcome of Single Dexamethasone Implant Injection in the Treatment of Persistent Diabetic Macular Edema After Anti-VEGF Treatment: Real-Life Data from a Tertiary Hospital in Jordan
par: Al-Latayfeh M, et autres
Publié: (2021)

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
par: Kaya C, et autres
Publié: (2019)

Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
par: Figueira J, et autres
Publié: (2021)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
par: Pacella E, et autres
Publié: (2020)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
par: Massin P, et autres
Publié: (2016)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
par: Zarranz-Ventura J, et autres
Publié: (2020)

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
par: Zarranz-Ventura J, et autres
Publié: (2020)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
par: Kim MS, et autres
Publié: (2021)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
par: Michalska-Małecka K, et autres
Publié: (2016)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
par: Andrzej Grzybowski, et autres
Publié: (2021)

Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
par: Javier Obis, et autres
Publié: (2021)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
par: Singer MA, et autres
Publié: (2016)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
par: Fouda SM, et autres
Publié: (2017)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
par: Xiu-Xian Wang, et autres
Publié: (2021)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
par: Wallsh J, et autres
Publié: (2016)

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
par: Elbarky AM
Publié: (2020)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
par: Joshi L, et autres
Publié: (2016)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
par: Wallsh J, et autres
Publié: (2020)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
par: Hall J
Publié: (2016)

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
par: Taylor K, et autres
Publié: (2020)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
par: Chen YX, et autres
Publié: (2020)

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
par: Veritti D, et autres
Publié: (2021)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
par: Ivanovska Adjievska B, et autres
Publié: (2017)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
par: Karttunen T, et autres
Publié: (2019)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment-Naïve Diabetic Macular Edema: A Prospective, Uncontrolled Pilot Study
par: Rush RB, et autres
Publié: (2021)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
par: Ume Sughra, et autres
Publié: (2021)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
par: Adán A, et autres
Publié: (2020)

Primary treatment of diabetic macular edema
par: Tushar M Ranchod, et autres
Publié: (2009)

Analysis of Funding Source and Spin in the Reporting of Studies of Intravitreal Corticosteroid Therapy for Diabetic Macular Edema: A Systematic Review
par: Nithianandan H, et autres
Publié: (2020)

Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
par: Chiara Altana, et autres
Publié: (2021)

Update on corticosteroids for diabetic macular edema
par: Schwartz SG, et autres
Publié: (2016)

Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial
par: Fonseca ALA, et autres
Publié: (2019)

Pseudophakic cystoid macular edema: update 2016
par: Grzybowski A, et autres
Publié: (2016)